4.6 Article

Loss of Stromal Caveolin-1 Expression: A Novel Tumor Microenvironment Biomarker That Can Predict Poor Clinical Outcomes for Pancreatic Cancer

Related references

Note: Only part of the references are listed.
Article Radiology, Nuclear Medicine & Medical Imaging

How to read and report CTC

Emanuele Neri et al.

EUROPEAN JOURNAL OF RADIOLOGY (2013)

Article Multidisciplinary Sciences

Isolation of Normal and Cancer-associated Fibroblasts from Fresh Tissues by Fluorescence Activated Cell Sorting (FACS)

Yoray Sharon et al.

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2013)

Review Pathology

Caveolin-1 and Cancer Metabolism in the Tumor Microenvironment: Markers, Models, and Mechanisms

Federica Sotgia et al.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 7 (2012)

Article Medicine, Research & Experimental

Caveolin-1 knockdown is associated with the metastasis and proliferation of human lung cancer cell line NCI-H460

Yang Song et al.

BIOMEDICINE & PHARMACOTHERAPY (2012)

Review Oncology

The role of caveolin-1 in human breast cancer

Neill Patani et al.

BREAST CANCER RESEARCH AND TREATMENT (2012)

Article Oncology

Challenges in the Enumeration and Phenotyping of CTC

Frank A. W. Coumans et al.

CLINICAL CANCER RESEARCH (2012)

Article Biochemistry & Molecular Biology

Her-2/neu and Topoisomerase IIα in Advanced Breast Cancer: A Comprehensive FISH Analysis of 245 Cases

Verena Engelstaedter et al.

DIAGNOSTIC MOLECULAR PATHOLOGY (2012)

Article Biochemistry & Molecular Biology

Caveolin-1 is essential for metformin inhibitory effect on IGF1 action in non-small-cell lung cancer cells

Barbara Salani et al.

FASEB JOURNAL (2012)

Article Cell Biology

The tumor microenvironment at a glance

Frances R. Balkwill et al.

JOURNAL OF CELL SCIENCE (2012)

Article Cell Biology

Co-expression of fatty acid synthase and caveolin-1 in pancreatic ductal adenocarcinoma

Agnieszka K. Witkiewicz et al.

CELL CYCLE (2008)